Plasma apelin levels and apelin/APJ mRNA expression in patients with gestational diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 87, Issue 2, 2010, Pages 176-183

  Telejko, Beata ^a   Kuzmicki, Mariusz ^a   Wawrusiewicz Kurylonek, Natalia ^a   Szamatowicz, Jacek ^a   Nikolajuk, Agnieszka ^a   Zonenberg, Anna ^a   Zwierz Gugala, Dorota ^a   Jelski, Wojciech ^a   Laudański, Piotr ^a   Wilczynski, Jan ^b   Kretowski, Adam ^a   Gorska, Maria ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Adiponectin; Adipose tissue; Apelin; APJ; Gestational diabetes mellitus; Placenta

Indexed keywords

APELIN; INSULIN; MESSENGER RNA;

ADULT; ARTICLE; CONTROLLED STUDY; DIET THERAPY; FEMALE; GENE EXPRESSION; GESTATION PERIOD; GLUCOSE TOLERANCE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; PLACENTA; PREGNANCY DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SUBCUTANEOUS FAT;

ADIPOSE TISSUE; ADULT; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PARITY; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; RECEPTORS, G-PROTEIN-COUPLED; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 74449090694     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.10.018     Document Type: Article

References (45)

1. Tatemoto K., Hosoya M., Habata Y., Fujii R., Kakegawa T., Zou M.X., et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem. Biophys. Res. Commun. 251 (1998) 471-476
2. Lee D.K., Cheng R., and Nguyen T. Characterization of apelin, the ligand for the APJ receptor. J. Neurochem. 74 (2000) 34-41
3. O'Carroll A.M., Selby T.L., Palkovits M., and Lolait S.J. Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim. Biophys. Acta 1492 (2000) 72-80
4. Kawamata Y., Habata Y., Fukusumi S., Hosoya M., Fujii R., Hinuma S., et al. Molecular properties of apelin: tissue distribution and receptor binding. Biochim. Biophys. Acta 1538 (2001) 162-171
5. De Falco M., De Luca L., Onori N., Cavallotti I., Artigiano F., Esposito V., et al. Apelin expression in normal human tissues. In Vivo 16 (2002) 333-336
6. Medhurst A.D., Jennings C.A., Robbins M.J., Davis R.P., Ellis C., Winborn K.Y., et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J. Neurochem. 84 (2003) 1162-1172
7. Cobellis L., De Falco M., Mastrogiacomo A., Giraldi D., Dattilo D., Scaffa C., et al. Modulation of apelin and APJ receptor in normal and preeclampsia-complicated placentas. Histol. Histopathol. 22 (2007) 1-8
8. Kleinz M.J., and Davenport A.P. Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regul. Pept. 118 (2004) 119-125
9. Falcao-Pires I., and Leite-Moreira A.F. Apelin: a novel neurohumoral modulator of the cardiovascular system: pathophysiologic importance and potential use as a therapeutic target. Rev. Port. Cardiol. 24 (2005) 1263-1276
10. Tatemoto K., Takayama K., Zou M.X., Kumaki I., Zhang W., Kumano K., et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul. Pept. 99 (2001) 87-92
11. Szokodi I., Tavi P., Foldes G., Voutilainen-Myllyla S., Ilves M., Tokola H., et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ. Res. 91 (2002) 434-440
12. Chen M.M., Ashley E.A., Deng D.X., Tsalenko A., Deng A., Tabibiazar R., et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 108 (2003) 1432-1439
13. Ishida J., Hashimoto T., Hashimoto Y., Nishiwaki S., Iguchi T., Harada S., et al. Regulatory roles for APJ, a seven-transmembrane receptor related to AT1, in blood pressure in vivo. J. Biol. Chem. 279 (2004) 26274-26279
14. Cheng X., Cheng X.S., and Pang C.C. Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ, receptor in conscious rats. Eur. J. Pharmacol. 470 (2003) 171-175
15. Ashley E.A., Powers J., Chen M., Kundu R., Finsterbach T., Caffarelli A., et al. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc. Res. 65 (2005) 73-82
16. Taheri S., Murphy K., Cohen M., Sujkovic E., Kennedy A., Dhillo W., et al. The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem. Biophys. Res. Commun. 291 (2002) 1208-1212
17. De Mota N., Reaux A., Messari S.E., Chartrel N., Roesch D., Dujardin C., et al. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin. Proc. Natl. Acad. Sci. USA 101 (2004) 10464-10469
18. Masri B., Morin N., Cornu M., Knibiehler B., and Audigier Y. Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB J. 18 (2004) 1909-1911
19. Saint-Geniez M., Argence C.B., Knibiehler B., and Audigier Y. The msr/apj gene encoding the apelin receptor is an early and specific marker of the venous phenotype in the retinal vasculature. Gene Expression Patterns 3 (2003) 467-472
20. Boucher J., Masri B., Daviaud D., Gesta S., Guigne C., Mazzucotelli A., et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146 (2005) 1764-1771
21. Wei L., Hou X., and Tatemoto K. Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes. Regul. Pept. 132 (2005) 27-32
22. Dray C., Knauf C., Daviaud D., Waget A., Boucher J., Buléon M., et al. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab. 8 (2008) 437-445
23. Castan-Laurell I., Vítkova M., Daviaud D., Dray C., Kovacikova M., Kovacova Z., et al. Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ. Eur. J. Endocrinol. 158 (2008) 905-910
24. Heinonen M.V., Purhonen A.K., Miettinen P., Paakkonen M., Pirinen E., Alhava E., et al. Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding. Regul. Pept. 130 (2005) 7-13
25. Li L., Yang G., Li Q., Tang Y., Yang M., Yang H., et al. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp. Clin. Endocrinol. Diabetes 114 (2006) 544-548
26. Erdem G., Dogru T., Tasci I., Sonmez A., and Tapan S. Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus. Exp. Clin. Endocrinol. Diabetes 116 (2008) 289-292
27. Barbour L.A., McCurdy C.E., Hernandez T.L., Kirwan J.P., Catalano P.M., and Friedman J.E. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 30 Suppl. 2 (2007) S112-S119
28. WHO Consultation. Definition, diagnosis, and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus, WHO/NCD/NCS/99.2, WHO, Geneva, 1999.
29. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
30. Iwanaga Y., Kihara Y., Takenaka H., and Kita T. Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system. J. Mol. Cell. Cardiol. 41 (2006) 798-806
31. Atluri P., Morine K.J., Liao G.P., Panlilio C.M., Berry M.F., Hsu V.M., et al. Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression. Cell. Mol. Biol. Lett. 12 (2007) 127-138
32. Rosenfeld C.R. Mechanisms regulating angiotensin II responsiveness by the uteroplacental circulation. Am. J. Physiol. 281 (2001) R1025-R1040
33. Williams D.J., Vallance P.J., Neild G.H., Spencer J.A., and Imms F.J. Nitric oxide-mediated vasodilation in human pregnancy. Am. J. Physiol. 272 (1997) H748-H752
34. O'Dowd B.F., Heiber M., Chan A., Heng H.H., Tsui L.C., Kennedy J.L., et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136 (1993) 355-360
35. Vickers C., Hales P., Kaushik V., Dick L., Gavin J., Tang J., et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J. Biol. Chem. 277 (2002) 14838-14843
36. Daviaud D., Boucher J., Gesta S., Dray C., Guigne C., Quilliot D., et al. TNF-α up-regulates apelin expression in human and mouse adipose tissue. FASEB J. 20 (2006) 1528-1530
37. Telejko B., Kuzmicki M., Zonenberg A., Szamatowicz J., Wawrusiewicz-Kurylonek N., Nikolajuk A., et al. Visfatin in gestational diabetes: serum level and mRNA expression in fat and placental tissue. Diab. Res. Clin. Pract. 84 (2009) 68-75
38. Worda C., Leipold H., Gruber C., Kautzky-Willer A., Knöfler M., and Bancher-Todesca D. Decreased plasma adiponectin concentrations in women with gestational diabetes. Am. J. Obstet. Gynecol. 191 (2004) 2120-2124
39. Cortelazzi D., Corbetta S., Ronzoni S., Pelle F., Marconi A., Cozzi V., et al. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin. Endocrinol. 66 (2007) 447-453
40. Williams M.A., Qiu C., Muy-Rivera M., Vadachkoria S., Son T., and Luthy D.A. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J. Clin. Endocrinol. Metab. 89 (2004) 2306-2611
41. Caminos J.E., Nogueiras R., Gallego R., Bravo S., Tovar S., Garcia-Caballero T., et al. Expression and regulation of adiponectin and receptor in human and rat placenta. J. Clin. Endocrinol. Metab. 90 (2005) 4276-4286
42. Chen J., Tan B., Karteris E., Zervou S., Digby F, Hillhouse W., et al. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia 49 (2006) 1292-1302
43. Corbetta S., Bulfamante G., Cortelazzi D., Barresi V., Cetin I., Mantovani G., et al. Adiponectin expression in human fetal tissues during mid- and late-gestation. J. Clin. Endocrinol. Metab. 90 (2004) 2397-2402
44. Haugen F., Ranheim T., Harsem N.K., Lips E., Staff A.C., and Drevon C.A. Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression. Am. J. Physiol. Endocrinol. Metab. 290 (2005) E326-E333
45. Meller M., Qiu C., Vadachkoria S., Abetew D.F., Luthy D.A., and Williams M.A. Changes in placental adipocytokine gene expression associated with gestational diabetes mellitus. Physiol. Res. 55 (2006) 501-512